Individuals who will be obtaining cyclosporine, tacrolimus or other agents to prevent graft-as opposed to-host disorder put up bone marrow transplant usually are not suitable for this trial "NCI is dedicated to sharing details in accordance with NIH policy. For more information on how medical trial info is shared, access https://ddrtrk181233.widblog.com/81570703/article-under-review